The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Looking at today's trades, it looks like tumble weed is in demand today! Who would have guessed.
............ ! That is all that can be discussed on here! As nothing else apart from a vastly reduced financial position over past 26 months!
Doc83.
The fact that shareholders, who care about the company and its future, requested more frequent feedback at the last AGM is significant.
Synairgen’s total disregard of a perfectly reasonable request speaks volumes about the arrogance of the CEO and BOD. I have no evidence, as such, but have long suspected that the company isn’t as well led as it ought to be? Obfuscation through a refusal to communicate is a means of covering up any lack of competence in the actions of the leadership group.
We will know soon enough, and can but hope that my thoughts turn out to be entirely misplaced, and that the company actually delivers appropriate P2 trials, as previously specified.
GLALTIs.
Isn't is just common courtesy to keep in communication with shareholders, even if it is just to say "we are still alive, remain on track and will provide updates as and when..."?
And Marsden played swingball with De Niro and nearly broke Bonnie Langford's back .
Agreed Doc.
Month 5 of the year and god knows how many millions spent in overheads and the only news we have is the company attended a presentation in Scotland a couple of weeks ago.
Does our CEO genuinely think that is how to treat shareholders following a 97% drop in share price whilst they live off the £85m fundraise.
Share something then Tom. Offer something to lift the level rather than moaning. What's the skinny on Reddit ? Everyone still chipper ? Better badinage I'm sure, but are you all still confident we'll be trialing within the next 2 months.
Posters on this bb haven't had anything substantive to discuss for more than 7 months & in truth it's become a little ragged. I'm sure our regular high quality service will resume when we get an update.
Come on Tommy. Stay positive.
Trials start next month!
What a joke LSE is lately. Not worth reading on a daily basis
Relax guys, the company is working at haste
Agreed Josh. When will they learn.
Usual BS touted by the usual suapects on here as always
Wpa5 i am not sure the trials are going to be short and sweet. At least one is apparently highly targeted, so whilst the cohort is small, it might take longer to recruit the required patients to meet the criteria. I am erring on the side of caution until more information is available.
Gunto ... 'P2 results Q1 2026' ... or did you mean Q1 2025 ?
Results are due, they require an update, RM
will have to confirm a H1 start or explain a delay..
I think we will all know where we are in the next few weeks..
Spac - perhaps the company could write out the proposed phase 2 trials of their business plan and that would solve any going concern issue. Just a thought.
Spacman, what kind of timeframes would you assign to the below statement? I would say two years.
“The Company’s cash resources are sufficient to cover its plans to design and establish data from an observational study and two investigator-led/Synairgen-sponsored Phase 2 clinical trials, including manufacture of active and placebo for use in these trials.”
Thanks for your expectations timeline Gunto. I don't think that Business Plan timeline would pass the Going Concern test they're possibly up against with the auditors currently, unless there's some funding solution, JV etc. announcement about to come.
I don’t think so Spac. I know you want some excitement but the company will plod on at the normal (pre pandemic) pace and the P2 will be under way when ready, results posted when ready and next steps will be announced when ready.
My updated timeline of expectations:
P2 start: q3-2024
P2 results: q1-2026
Happy if earlier but can’t see it at the moment.
On the flip side, I do think there is more than meets the eye to the recent joint presentation with the UK Health Authority. The mention of pandemic preparedness does lead my eye towards the 100 Days Mission.
Pot calling kettle MrCosts ‘ Gunto - you are trying really hard to luck clever.’….
‘look’ not ‘luck’.
Gunto - of course TFG will be totally supportive of the management until the day they they aren't. In a heartbeat they will pounce, they can pull over £100m back potentially, they won't just let things fester with an inadequate management.
The natural order here is that SNG001 should now be in the hands of a BP that has done hundreds of thousands of P2's and P3's. By contrast the Synairgen team, with the exception of Mankowski, have done a handful. Even Mankowski has infinitesimal experience by comparison to the combined institutional history of a BP. I hope SSH is realising that it's time to move this on.
MrCosts
Posted in: SNG
Posts: 1,498
Price: 5.00
No Opinion
Trades are increasing11 Mar 2024 14:08
10p by end of the week! jUsT mY GuEsS.
…….
Well done to Mr Costs.
Gunto - you are trying really hard to luck clever.
The majority of the TFG investment was pre phase 3 results. They bought between £2 and say £1.00. The share price is now c. 6p.
The interview with Reade Griffith (I believe is Oct 2022) after trial failure. That doesn't tell you anything about how Synairgen will turn this mess around.
I don't understand the link the between one interview which means everything will come good.
Haha Mr Costs. Clearly but bought more stock when he wrote “buys are coming in so there must be news close!” lol! I guess he forgot to sell (again).
I am not in the know but I did bother to watch the Reade Griffith interview where he discussed the investment strategy of TFG. It is out there on YouTube and for those with a longer attention span than 5mins, you can learn a thing or two and gain some insight as to what is ‘most likely’ going on here.
Gunto - why are you pretending you are in the know.
Johnnyboy - 'the science' - I'm sure we failed our last phase 3 and the drug hasn't been used since Nov 21. 'The science' sounds like an old banger that won't start.
Oh and timeframes. RNS April 2022 (yes 2022) stated they were considering new trials. RNS September 2023 states trials would start by end of 2023.
We are currently 'on track' for an already delayed trial start date.
Nothing to worry about here.